Skip to main content

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy

Access & Citations

  • 822
    Article Accesses
  • 0
    Web of Science
  • 5
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.